Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
General Primary Care
•
Women
How do you decide when to taper women on HRT for vasomotor symptoms of menopause? And what is your recommended taper?
Related Questions
Do you start bisphosphonates after tapering off menopausal hormone therapy to prevent the rapid decline of bone mineral density?
Do you frequently recommend the HPV vaccination series to patients above 26 years old?
How to you approach the risk/benefit discussion for hormone replacement therapy in perimenopausal women with significant vasomotor symptoms and borderline ASCVD risk?
How would you approach hormone replacement therapy for perimenopause in a patient with increased risk factors for VTE?
What are some practical tips in distinguishing between metabolic bone disease due to chronic kidney disease and osteoporosis?
What is your strategy for counseling patients who don't qualify for colorectal cancer (CRC) screening under the current guidelines but are concerned with its increasing incidence at a younger age?
What is your approach to bisphosphonate use in patients with advanced chronic kidney disease and osteoporosis?
How do you use NT-proBNP in patients with chronic kidney disease or end-stage kidney disease, given that these conditions can affect NT-proBNP levels?
What therapies do you recommend for patients with limited life expectancy (<3 months) but whose depression is significantly reducing their quality of life?
What history or physical exam findings do you find most helpful to distinguish peripheral versus central causes of vertigo in the primary care setting?
